VEGFA and diabetes mellitus: Considering the rising global prevalence of diabetes and associated visual complications of DME, as well as the limited healthcare resources, it is crucial to ideally adjust the therapeutic strategy of anti-VEGF therapy to optimize clinical care for DME.